Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ)
CNY 19.22
(0.26%)
CNY 19.22
(0.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.24 Billion | 2.08 Billion | 2 Billion | 2 Billion | 1.46 Billion | 1.18 Billion |
| Cost of Revenue | 1.13 Billion | 1.07 Billion | 967.36 Million | 919.39 Million | 699.15 Million | 593.59 Million |
| Gross Profit | 1.11 Billion | 1 Billion | 1.03 Billion | 1.08 Billion | 767.42 Million | 596.27 Million |
| Operating Expenses | 695.37 Million | 612.8 Million | 632.77 Million | 629.37 Million | 510.16 Million | 414.2 Million |
| Selling, General and Administrative Expenses | 419.52 Million | 388.05 Million | 428.01 Million | 413.27 Million | 328.12 Million | 274.64 Million |
| Research and Development Expenses | 172.94 Million | 132.67 Million | 117.68 Million | 111.52 Million | 94.79 Million | 80.32 Million |
| Other Expenses | - | 21.53 Million | 91.07 Million | 96.83 Million | 59.27 Million | 251.29 Thousand |
| Cost and Expenses | 1.82 Billion | 1.68 Billion | 1.6 Billion | 1.54 Billion | 1.2 Billion | 1 Billion |
| Operating Income | 565.23 Million | 416.63 Million | 499.35 Million | 513.12 Million | 263.06 Million | 161.69 Million |
| Interest Expense | 24.32 Million | 28.43 Million | 23.82 Million | 27.17 Million | 24.51 Million | 17.25 Million |
| Income Tax Expense | 55.66 Million | 40.04 Million | 54.19 Million | 71.42 Million | 36.11 Million | 20.9 Million |
| Earnings before Tax | 545.32 Million | 413.81 Million | 487.78 Million | 510.91 Million | 259.91 Million | 161.94 Million |
| Net Income | 452.94 Million | 346.69 Million | 412.78 Million | 398.19 Million | 194.35 Million | 118.97 Million |
| Earnings Per Share Basic | 0.98 | 0.74 | 0.88 | 0.99 | 0.49 | 0.29 |
| Earnings Per Share Diluted | 0.98 | 0.74 | 0.88 | 0.99 | 0.49 | 0.29 |
| Weighted Average Shares Outstanding | 463.51 Million | 468.01 Million | 466.45 Million | 402.47 Million | 397.13 Million | 404.49 Million |
| Weighted Average Shares Outstanding (Diluted) | 463.51 Million | 468.01 Million | 466.45 Million | 402.47 Million | 397.13 Million | 404.55 Million |
| Gross Margin | 0.50 | 0.48 | 0.52 | 0.54 | 0.52 | 0.50 |
| EBIT Margin | 0.32 | 0.26 | 0.31 | 0.32 | 0.29 | 0.24 |
| Profit Margin | 0.20 | 0.17 | 0.21 | 0.20 | 0.13 | 0.10 |
| EBITDA | 711.43 Million | 553.97 Million | 595.34 Million | 634.12 Million | 378.85 Million | 277.43 Million |
| Earnings Before Tax Margin | 0.25 | 0.20 | 0.25 | 0.26 | 0.18 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 647.76 Million | 558.43 Million | 533.19 Million | 661.79 Million | 2.24 Billion | 593.06 Million |
| Cost of Revenue | 318.21 Million | 305.81 Million | 278.72 Million | 352.97 Million | 1.13 Billion | 301.15 Million |
| Gross Profit | 329.55 Million | 252.61 Million | 254.47 Million | 308.82 Million | 1.11 Billion | 291.91 Million |
| Operating Expenses | 206.17 Million | 179.3 Million | 148.75 Million | 194.81 Million | 695.37 Million | 173.94 Million |
| Selling, General and Administrative Expenses | 284.92 Million | 138.24 Million | 111.46 Million | 37.33 Million | - | 184.87 Million |
| Research and Development Expenses | 51.68 Million | 41.37 Million | 36.41 Million | 48.75 Million | - | 47.19 Million |
| Other Expenses | -130.43 Million | 319.07 Thousand | -296.95 Thousand | 2.08 Million | 1.44 Million | 7576.68 |
| Cost and Expenses | 524.38 Million | 485.12 Million | 427.48 Million | 547.79 Million | 1.82 Billion | 475.1 Million |
| Operating Income | 114.99 Million | 73.3 Million | 105.37 Million | 238.51 Million | 565.23 Million | 110.82 Million |
| Interest Expense | 8.38 Million | 6.98 Million | 6.34 Million | 5.96 Million | 24.32 Million | 6.04 Million |
| Income Tax Expense | 17.6 Million | 8.92 Million | 11.57 Million | 24.47 Million | 55.66 Million | 9.55 Million |
| Earnings before Tax | 113.97 Million | 81.62 Million | 105.07 Million | 240.59 Million | 566.68 Million | 110.97 Million |
| Net Income | 85.59 Million | 71.56 Million | 87.57 Million | 179.24 Million | 452.94 Million | 95.42 Million |
| Earnings Per Share Basic | 0.18 | 0.16 | 0.19 | 0.38 | - | 0.20 |
| Earnings Per Share Diluted | 0.18 | 0.16 | 0.19 | 0.38 | - | 0.20 |
| Weighted Average Shares Outstanding | 465.84 Million | 460.24 Million | 460.65 Million | 466.27 Million | 466.27 Million | 466.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 465.84 Million | 460.24 Million | 460.65 Million | 466.27 Million | 466.27 Million | 466.27 Million |
| Gross Margin | 0.51 | 0.45 | 0.48 | 0.47 | 0.50 | 0.49 |
| EBIT Margin | 0.19 | 0.21 | 0.20 | 0.16 | - | 0.20 |
| Profit Margin | 0.13 | 0.13 | 0.16 | 0.27 | 0.20 | 0.16 |
| EBITDA | 122.36 Million | 118.33 Million | 106.72 Million | 109 Million | - | 121.18 Million |
| Earnings Before Tax Margin | 0.18 | 0.13 | 0.20 | 0.36 | 0.25 | 0.19 |
AWR
601628
600722
600569
GSS
VEON